UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of gastric cancer in Asia: resource-stratified guidelines

The lancet oncology, 2013-11, Vol.14 (12), p.e535-e547

2013

Volltextzugriff (PDF)

Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma

Hepatology international, 2024-06, Vol.18 (3), p.973-983

2024

Volltextzugriff (PDF)

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study

Gastrointestinal endoscopy, 2010-07, Vol.72 (1), p.25-32

2010

Volltextzugriff (PDF)

Is the New Seventh AJCC/UICC Staging System Appropriate for Patients with Gastric Cancer?

Journal of the American College of Surgeons, 2012, Vol.214 (1), p.88-96

2012

Volltextzugriff (PDF)

Management of gastric cancer: East vs west

Current problems in cancer, 2015-11, Vol.39 (6), p.315-341

Ryun Park, Sook, MD, PhD

2015

Volltextzugriff (PDF)

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Cancer, 2008-06, Vol.112 (11), p.2368-2376

2008

Volltextzugriff (PDF)

Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors

Investigational new drugs, 2014-04, Vol.32 (2), p.340-346

2014

Volltextzugriff (PDF)

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Journal of cancer education, 2020-06, Vol.35 (3), p.545-556

2020

Volltextzugriff (PDF)

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

Cancer chemotherapy and pharmacology, 2014-02, Vol.73 (2), p.343-348

2014

Volltextzugriff (PDF)

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Oncoimmunology, 2024-12, Vol.13 (1), p.2371563

2024

Volltextzugriff (PDF)

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Cancer science, 2010-03, Vol.101 (3), p.793-799

2010

Volltextzugriff (PDF)

Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer

Journal of surgical oncology, 2008-10, Vol.98 (5), p.331-335

2008

Volltextzugriff (PDF)

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Liver cancer (Basel ), 2021-04, Vol.10 (2), p.107-114

2021

Volltextzugriff (PDF)

Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients

Journal of the American College of Surgeons, 2009-10, Vol.209 (4), p.461-467

2009

Volltextzugriff (PDF)

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

Nature communications, 2023-04, Vol.14 (1), p.2017-2017, Article 2017

2023

Volltextzugriff (PDF)

A Functional Single Nucleotide Polymorphism in Mucin 1 , at Chromosome 1q22, Determines Susceptibility to Diffuse-Type Gastric Cancer

Gastroenterology (New York, N.Y. 1943), 2011-03, Vol.140 (3), p.892-902

2011

Volltextzugriff (PDF)

Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based study

Frontiers in oncology, 2023, Vol.13, p.1295923-1295923

2023

Volltextzugriff (PDF)

Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients: A Viewpoint in the Era of Preoperative Treatment

Annals of surgery, 2010-03, Vol.251 (3), p.428-435

2010

Volltextzugriff (PDF)

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma

Hepatology communications, 2020-07, Vol.4 (7), p.1073-1086

2020

Volltextzugriff (PDF)

Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment

Hematology/oncology clinics of North America, 2012-06, Vol.26 (3), p.649-670

2012

Volltextzugriff (PDF)

613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A698-A698

2023

Volltextzugriff (PDF)

Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221097934-17588359221097934

2022

Volltextzugriff (PDF)

Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees

European journal of gastroenterology & hepatology, 2009-08, Vol.21 (8), p.855-860

2009

Volltextzugriff (PDF)

Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: A comparative study with laparoscopy-assisted distal gastrectomy

Journal of surgical oncology, 2009-10, Vol.100 (5), p.392-395

2009

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

ThemaChemotherapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Englisch
(210)
Koreanisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of gastric cancer in Asia: resource-stratified guidelines

Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma

Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study

Is the New Seventh AJCC/UICC Staging System Appropriate for Patients with Gastric Cancer?

Management of gastric cancer: East vs west

Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer

Weekly EZN-2208 (PEGylated SN-38) in combination with bevacizumab in patients with refractory solid tumors

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers

Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors

A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12)

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer

Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study

Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09

Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

A Functional Single Nucleotide Polymorphism in Mucin 1 , at Chromosome 1q22, Determines Susceptibility to Diffuse-Type Gastric Cancer

Detection and evaluation of signals for immune-related adverse events: a nationwide, population-based study

Prognostic Value of Preoperative Clinical Staging Assessed by Computed Tomography in Resectable Gastric Cancer Patients: A Viewpoint in the Era of Preoperative Treatment

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma

Poly(Adenosine Diphosphate–Ribose) Polymerase Inhibitors in Cancer Treatment

613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis

Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees

Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: A comparative study with laparoscopy-assisted distal gastrectomy

Aktive Filter

Suchergebnisse filtern